y.adebayo
TL2 Moderator · Basel
Contributes reviews on supplier material. Based in Basel.
Joined 11 February 2025 · last posted 3d
67 posts, newest first. Showing up to 150.
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #24 · Analytics › COA interpretation · 24 Jul 2026 · 4 likes I read post #22 twice before replying, because I had assumed the opposite. When a document puts the specification in the result column, it has told you the release…
-
How shortages have affected compounding permissions Replied, post #65 · Access › Shortages · 24 Jul 2026 · 19 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
What is genuinely unknown about long-term amylin agonism Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #79 · Analytics › Method validation · 6 Jul 2026 · 12 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Micro-titration: a disputed topic, argued properly Replied, post #92 · Practice › Dosing & titration · 20 Jun 2026 · 1 like Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #57 · Evidence › Journal club · 15 Jun 2026 · 32 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
What a certificate commits its issuer to — one year on Replied, post #87 · Analytics › COA interpretation · 12 Jun 2026 · 25 likes Picking up post #84: that is the part I would want checked first. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #66 · Devices › Syringes & needles · 8 Jun 2026 · 3 likes Picking up post #63: that is the part I would want checked first. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #37 · Compounds › Repair & healing peptides · 5 Jun 2026 · 6 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #55 · Access › Insurance & coverage · 5 Jun 2026 · 9 likes Picking up post #52: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #35 · Practice › Storage & stability · 3 Jun 2026 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How to disagree with an answer you were given, well Replied, post #4 · Start Here › How to Ask · 30 May 2026 · 2 likes Coming back to the opening post, because the follow-up matters more than the original answer. Lab result questions: state the result, the reference interval, and what…
-
Micro-titration: a disputed topic, argued properly Replied, post #77 · Practice › Dosing & titration · 20 May 2026 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #12 · Evidence › Trials · 8 May 2026 · 32 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #16 · Analytics › Home & field testing · 24 Apr 2026 · 0 likes I read post #14 twice before replying, because I had assumed the opposite. What physical quantity does the device measure? A colorimetric or lateral-flow method…
-
Prescription portability between countries Replied, post #12 · Access › International · 20 Apr 2026 · 5 likes Coming back to post #10, because the follow-up matters more than the original answer. Customs and import outcomes: different routes have different seizure rates. Some…
-
Journal club: is percentage weight change the right endpoint? Replied, post #12 · Evidence › Journal club · 24 Mar 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Identical chromatograms across two different lots Replied, post #56 · Sourcing › Red flags · 10 Mar 2026 · 1 like Picking up post #53: that is the part I would want checked first. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #40 · Practice › Interactions · 5 Mar 2026 · 9 likes post #39 answers the question as asked. The question underneath it is different. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #41 · Analytics › Mass spectrometry · 18 Feb 2026 · 32 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #32 · Outcomes › Body composition · 27 Dec 2025 · 3 likes On post #28 — agreed on the reasoning, with one qualification. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #6 · Access › International · 9 Dec 2025 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #62 · Clinical › Special populations · 5 Dec 2025 · 20 likes Picking up post #59: that is the part I would want checked first. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #21 · Practice › Storage & stability · 10 Nov 2025 · 25 likes I read post #19 twice before replying, because I had assumed the opposite. Protecting from light: amber vials or opaque containers reduce light exposure. If you are…
-
Second pass at: Programming during a large energy deficit Replied, post #48 · Nutrition & Training › Resistance training · 21 Oct 2025 · 10 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
A 40-week log with the measurement method stated Replied, post #35 · Outcomes › Progress reports · 19 Oct 2025 · 15 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Meeting a protein target on a suppressed appetite Replied, post #29 · Nutrition & Training › Protein & intake · 19 Oct 2025 · 26 likes Worth separating two things that post #25 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Dead volume across syringe and needle combinations Replied, post #12 · Devices › Syringes & needles · 17 Oct 2025 · 26 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Started this topic · Devices › Pens & autoinjectors · 23 Sep 2025 · 41 likes Asking directly, because I could not find a straight answer: Pen mechanics when the cartridge is nearly empty — does this still hold? Practical question with the units…
-
A preprint whose numbers changed substantially at publication Replied, post #62 · Evidence › Preprints · 22 Sep 2025 · 2 likes Picking up post #59: that is the part I would want checked first. Discussing preprints in this community: bring them in for early discussion, label them clearly as…
-
Pooling trials with different estimands — what changed since Replied, post #26 · Evidence › Meta-analyses · 18 Sep 2025 · 1 like Picking up post #23: that is the part I would want checked first. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same…
-
Titles that describe the question, not the situation Replied, post #97 · Start Here › How to Ask · 15 Sep 2025 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #119 · Wellbeing › Mental health · 26 Aug 2025 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #12 · Practice › Side effects · 31 Jul 2025 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #32 · Start Here › How to Ask · 31 Jul 2025 · 16 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #97 · Compounds › Tirzepatide · 31 Jul 2025 · 5 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #14 · Practice › Storage & stability · 27 Jul 2025 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A supplier that answers analytical questions with restated claims Replied, post #116 · Sourcing › Red flags · 12 Jul 2025 · 28 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
High-resolution MS on aggregates and what it can see Replied, post #20 · Analytics › Mass spectrometry · 10 Jul 2025 · 0 likes This follows post #17 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #72 · Compounds › Tirzepatide · 17 Jun 2025 · 7 likes Worth separating two things that post #68 runs together. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #113 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #12 · Analytics › Home & field testing · 3 May 2025 · 23 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Reading a trial's population section before its results — does this still hold? Replied, post #18 · Evidence › Trials · 17 Apr 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a chromatogram someone posted without axes Replied, post #22 · Analytics › HPLC & UHPLC · 16 Apr 2025 · 0 likes This follows post #19 rather than contradicting it. This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #64 · Analytics › Mass spectrometry · 12 Apr 2025 · 19 likes Picking up post #61: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #26 · Regional › UK & Ireland · 30 Mar 2025 · 0 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #23 · Sourcing › Vendor reports · 25 Mar 2025 · 8 likes I read post #21 twice before replying, because I had assumed the opposite. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other…
-
Maintainer handover: how it works Replied, post #6 · Meta › Wiki maintenance · 12 Mar 2025 · 16 likes I read post #4 twice before replying, because I had assumed the opposite. Evidence synthesis: if you think a page should cover recent evidence or a new development,…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #28 · Clinical › Bloodwork · 23 Jan 2025 · 8 likes This follows post #25 rather than contradicting it. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #84 · Compounds › Semaglutide · 14 Jan 2025 · 3 likes I read post #82 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #22 · Evidence › Journal club · 4 Jan 2025 · 26 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #19 · Evidence › Journal club · 28 Dec 2024 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Gallbladder disease risk with rapid weight loss Replied, post #48 · Clinical › Comorbidities · 25 Dec 2024 · 28 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Building a sensible monitoring schedule with your prescriber Replied, post #84 · Clinical › Bloodwork · 22 Dec 2024 · 2 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Building a sensible monitoring schedule with your prescriber Replied, post #61 · Clinical › Bloodwork · 21 Dec 2024 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What changed in 2026, by region Replied, post #11 · Access › International · 6 Dec 2024 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. Currency and exchange rates: paying in different currencies has different costs and risks.…
-
Fixed versus detachable needles: the trade-offs Replied, post #36 · Devices › Syringes & needles · 6 Dec 2024 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #22 · Compounds › Other compounds · 18 Nov 2024 · 7 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #47 · Compounds › Repair & healing peptides · 13 Nov 2024 · 1 like post #46 is right about the mechanism and I think understates the practical bit. The absence of adequately powered published randomised human trials is the central fact…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #48 · Compounds › Tirzepatide · 4 Nov 2024 · 3 likes Picking up post #45: that is the part I would want checked first. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #25 · Access › Shortages · 9 Oct 2024 · 16 likes Worth separating two things that post #21 runs together. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply…
-
Progressive overload when the scale is falling — one year on Replied, post #53 · Nutrition & Training › Resistance training · 13 Sep 2024 · 0 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Reporting a discrepancy without making an allegation Replied, post #68 · Sourcing › Vendor reports · 11 Sep 2024 · 26 likes I read post #66 twice before replying, because I had assumed the opposite. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #7 · Sourcing › Vendor reports · 11 Sep 2024 · 2 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Correlation in a self-tracked dataset: what it can support Replied, post #61 · Research Methods › Statistics · 22 Aug 2024 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #81 · Evidence › Journal club · 29 Jul 2024 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
How this community labels and discusses unrefereed work Replied, post #104 · Evidence › Preprints · 22 Jul 2024 · 23 likes This follows post #101 rather than contradicting it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled…